Pharmacology and clinical use of voriconazole

George R. Thompson, James S. Lewis

Research output: Contribution to journalReview articlepeer-review

44 Scopus citations


Importance of the field: Voriconazole is an extended-spectrum triazole developed specifically to target Aspergillus spp. and is now indicated as primary therapy in this circumstance. However, it has a broad spectrum of activity against both yeasts and molds and is also a viable treatment option in the treatment of other mycoses. Areas covered in this review: This review discusses the mechanism of action, the pharmacodynamics and pharmacokinetics and the most common mechanisms of resistance to this agent. An overview of therapeutic drug monitoring, drugdrug interactions and pivotal trials are also reviewed. What the reader will gain: The reader will gain further knowledge of the unique aspects of voriconazole compared to other currently available antifungal agents. Take home message: Voriconazole offers distinct advantages over several other antifungals. The side effect profile of voriconazole is unique compared to other triazole agents. Concern for drugdrug interactions due to a frequently shared common metabolic pathway has prompted heightened interest in the use of therapeutic drug monitoring for concerns of toxicity, drugdrug interactions and in attempts to ensure efficacy. These aspects as well as a review of important clinical information pertaining to voriconazole are discussed here.

Original languageEnglish (US)
Pages (from-to)83-94
Number of pages12
JournalExpert Opinion on Drug Metabolism and Toxicology
Issue number1
StatePublished - Jan 2010


  • Serum drug levels
  • Therapeutic drug monitoring
  • Voriconazole

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology


Dive into the research topics of 'Pharmacology and clinical use of voriconazole'. Together they form a unique fingerprint.

Cite this